These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 37255816)

  • 1. Role of obesity related inflammation in pathogenesis of peripheral artery disease in patients of type 2 diabetes mellitus.
    Yadav U; Kumar N; Sarvottam K
    J Diabetes Metab Disord; 2023 Jun; 22(1):175-188. PubMed ID: 37255816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Serum TNF-
    Alzamil H
    J Obes; 2020; 2020():5076858. PubMed ID: 32089876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked?
    Rehman K; Akash MS
    J Biomed Sci; 2016 Dec; 23(1):87. PubMed ID: 27912756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes.
    Zatterale F; Longo M; Naderi J; Raciti GA; Desiderio A; Miele C; Beguinot F
    Front Physiol; 2019; 10():1607. PubMed ID: 32063863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiometabolic Risk Factors Associated With Type 2 Diabetes Mellitus: A Mechanistic Insight.
    Chakraborty S; Verma A; Garg R; Singh J; Verma H
    Clin Med Insights Endocrinol Diabetes; 2023; 16():11795514231220780. PubMed ID: 38148756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats.
    Liu HQ; Qiu Y; Mu Y; Zhang XJ; Liu L; Hou XH; Zhang L; Xu XN; Ji AL; Cao R; Yang RH; Wang F
    Nutr Res; 2013 Oct; 33(10):849-58. PubMed ID: 24074743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of metaflammation as a systemic manifestation of metabolic diseases].
    Schäffler A
    Inn Med (Heidelb); 2023 Apr; 64(4):313-322. PubMed ID: 36346457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on immune dysregulation in obesity-related insulin resistance.
    Daryabor G; Kabelitz D; Kalantar K
    Scand J Immunol; 2019 Apr; 89(4):e12747. PubMed ID: 30593678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CD20+ T cells in cancer, autoimmunity and obesity.
    Pinho ACO; Laranjeira P; Carvalho E
    J Endocrinol; 2024 Mar; 260(3):. PubMed ID: 38236766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut-targeted therapies for type 2 diabetes mellitus: A review.
    Xu TC; Liu Y; Yu Z; Xu B
    World J Clin Cases; 2024 Jan; 12(1):1-8. PubMed ID: 38292634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance.
    Lee BC; Lee J
    Biochim Biophys Acta; 2014 Mar; 1842(3):446-62. PubMed ID: 23707515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.
    Murakami T; Inagaki N; Kondoh H
    Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes.
    Esser N; Legrand-Poels S; Piette J; Scheen AJ; Paquot N
    Diabetes Res Clin Pract; 2014 Aug; 105(2):141-50. PubMed ID: 24798950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol 25-hydroxylase (CH25H) as a promoter of adipose tissue inflammation in obesity and diabetes.
    Russo L; Muir L; Geletka L; Delproposto J; Baker N; Flesher C; O'Rourke R; Lumeng CN
    Mol Metab; 2020 Sep; 39():100983. PubMed ID: 32229247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA3 as an immunomodulator in obesity-related metabolic dysfunction associated with fatty liver disease, insulin resistance, and type 2 diabetes.
    El-Arabey AA; Abdalla M
    Chem Biol Interact; 2022 Oct; 366():110141. PubMed ID: 36058260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of immune attack in the progression of obesity-related type 2 diabetes.
    Wang HW; Tang J; Sun L; Li Z; Deng M; Dai Z
    World J Diabetes; 2023 May; 14(5):494-511. PubMed ID: 37273249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.
    Aroor AR; McKarns S; Demarco VG; Jia G; Sowers JR
    Metabolism; 2013 Nov; 62(11):1543-52. PubMed ID: 23932846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
    Black PH
    Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remodeling adipose tissue inflammasome for type 2 diabetes mellitus treatment: Current perspective and translational strategies.
    Banerjee A; Singh J
    Bioeng Transl Med; 2020 May; 5(2):e10150. PubMed ID: 32440558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.